Skip to main content
Quest Diagnostics

A Comprehensive Genomic Framework for Identifying Genes Predisposing to Homologous Recombination Repair-Deficient Breast or Ovarian Cancer

A Comprehensive Genomic Framework for Identifying Genes Predisposing to Homologous Recombination Repair-Deficient Breast or Ovarian Cancer

Authors: Camacho-Valenzuela J, Matis T, Roca C, Cuamatzi Flores JL, Hamel N, Rivera B, Gravel S, Polak P, Robles-Espinoza CD, Foulkes WD

Citation: BJC Rep. 2026 Apr 8;4(1):15. doi: 10.1038/s44276-026-00218-w

Specialties: Genetics, Oncology, Women's health, OB/GYN

Related content

Publication
Multicenter Evaluation of 2 Vaginal Self-Collection Devices for HPV Testing
Publication
Probing the Relevance of BRCA1 and BRCA2 Germline Pathogenic Variants Beyond Breast and Ovarian Cancer
Test FAQ
Hereditary Breast Cancer Panel
Publication
Tracking Response to Neoadjuvant Systemic Therapy Through Circulating Tumor DNA Analysis in Breast Cancer
Audio Podcast
Enhancing Cancer Treatment Decisions With Ultrasensitive MRD Testing
Audio Podcast
Exploring Digital Pathology and Artificial Intelligence
Publication
Evolution and Co-Occurrence of PI3K Pathway Gene Mutations in Endometrial Carcinoma Molecular Subtypes at the Single-Cell Level

Our company

Quest® is the brand name used for services offered by Quest Diagnostics Incorporated and its affiliated companies. Quest Diagnostics Incorporated and certain affiliates are CLIA-certified laboratories that provide HIPAA-covered services.  Other affiliates operated under the Quest® brand, such as Quest Consumer Inc., do not provide HIPAA-covered services. 

 

Quest®, Quest Diagnostics®, any associated logos, and all associated Quest Diagnostics registered or unregistered trademarks are the property of Quest Diagnostics. All third-party marks—® and ™—are the property of their respective owners. © 2026 Quest Diagnostics Incorporated. All rights reserved. Image content features models and is intended for illustrative purposes only.